Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial"

Marco Marietta; Armando Tripodi

doi:10.2450/2020.0116-20

Letter to the Editor

Blood Transfusion - 3 2020 (May-June)

Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial"

Marco Marietta , Armando Tripodi

DOI: 10.2450/2020.0116-20

Publication Date: 2020-05-07

Abstract

Preview
Dear Sir,
We appreciate the interest of Cattaneo and Morici in the SISET position paper on COVID-19 and haemostasis1,2.
In their comments1, they underline several interesting points relevant to the management of venous thrombosis prophylaxis in COVID-19 patients. [ … ]

PDF

Details
Statistics

Authors

Marco Marietta - Department of Oncology and Haematology, University Hospital, Modena, Italy

Armando Tripodi - "IRCCS Ca’ Granda Maggiore” Hospital Foundation, “Angelo Bianchi Bonomi” Haemophilia and Thrombosis Center and “Fondazione Luigi Villa”, Milan, Italy

Abstract viewed - 206 times
PDF downloaded - 32 times

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Abstract

Downloads

Authors